Androgens for Poor Responders in In Vitro Fertilization

Ovarian Response Clinical Trial

Official title:
Transdermal Testosterone to Improve Ovarian Response to Gonadotropins in Poor Responder IVF Patients With Normal Basal Concentrations of FSH

Status Completed

Clinical Trial Summary

it has been shown that androgens in non human primates may favour follicular growth in the ovaries when animals are treated with gonadotropins which are the hormones used in patients receiving treatment with in vitro fertilization. Therefore, this study investigates the potential usefulness of testosterone treatment preceding gonadotropin administration in in vitro fertilization patients having a previous poor response to gonadotropins alone.

Clinical Trial Description

n/a

Study Design

N/A

Related Conditions & MeSH terms

Ovarian Response

Clinical Trial Details

NCT number	NCT00693108
Study type	Interventional
Source	Hospital Clinic of Barcelona
Contact
Status	Completed
Phase	Phase 3
Start date	September 2006

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04168892` - Anti-Müllerian Hormone (AMH) Measured With Fully Automated Assay Versus AFC in the Prediction of Ovarian Response
Completed	`NCT00870025` - Human Chorionic Gonadotropin (hCG) Priming Prior to Controlled Ovarian Hyperstimulation (COH) in Poor Responder In Vitro Fertilization (IVF) Patients	Phase 4
Completed	`NCT00844350` - The Effect of Oxytocin (OT) and Oxytocin Plus Human Chorionic Gonadotropin (hCG), in Cycles Induced by Letrozole or Clomiphene Citrate	Phase 2